(formerly listed as Phase 0) - A phase of research used to describe exploratory trials conducted before traditional phase 1 trials to investigate how or whether a drug affects the body. They involve very limited human exposure to the drug and have no therapeutic or diagnostic goals (for example, screening studies, microdose studies).
Quoted from the ClinicalTrials.gov Glossary of Common Site Terms.
